Justin D. Hoopes

Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro

Jack Nguyen, Justin D. Hoopes, Lê Minh Hà et al. · PLoS ONE · 2010 · 174 citations · Full text

Triple Combination, Medicine, Antiviral Drug Development +12

TLR3 Deletion Limits Mortality and Disease Severity due to Phlebovirus Infection

Brian B. Gowen, Justin D. Hoopes, Min‐Hui Wong et al. · The Journal of Immunology · 2006 · 128 citations

Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro

Jack Nguyen, Justin D. Hoopes, Donald F. Smee et al. · Antimicrobial Agents and Chemotherapy · 2009 · 114 citations · Full text

Triple Combination, Medicine, Triple Combinations +11

Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin

Dale L. Barnard, Craig W. Day, Kevin W. Bailey et al. · Antiviral Research · 2006 · 104 citations

Medicine, Antiviral Drug Development, Antiviral Therapy +7

Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial

John H. Beigel, Yajing Bao, Joy Beeler et al. · The Lancet Infectious Diseases · 2017 · 94 citations · Full text

Antiviral Drug Development, Antiviral Therapy, Virology +5